Erste Asset Management GmbH bought a new stake in Grail, Inc. (NASDAQ:GRAL – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 6,168 shares of the company’s stock, valued at approximately $120,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. FNY Investment Advisers LLC acquired a new stake in shares of Grail in the 4th quarter valued at $26,000. Lindbrook Capital LLC acquired a new position in Grail during the 4th quarter worth about $28,000. New York State Common Retirement Fund acquired a new position in Grail during the 4th quarter worth about $59,000. Wilmington Savings Fund Society FSB acquired a new position in Grail during the 4th quarter worth about $64,000. Finally, PNC Financial Services Group Inc. acquired a new position in Grail during the 4th quarter worth about $86,000.
Insider Buying and Selling at Grail
In other news, CEO Robert P. Ragusa sold 7,625 shares of the company’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the sale, the chief executive officer now directly owns 828,662 shares of the company’s stock, valued at $25,862,541.02. This represents a 0.91 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Aaron Freidin sold 1,816 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the sale, the chief financial officer now directly owns 335,170 shares of the company’s stock, valued at approximately $10,457,304. This trade represents a 0.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,550 shares of company stock worth $360,436.
Grail Stock Performance
Grail (NASDAQ:GRAL – Get Free Report) last released its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. As a group, equities analysts expect that Grail, Inc. will post -15.15 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Separately, Morgan Stanley started coverage on shares of Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price target on the stock.
Get Our Latest Analysis on Grail
About Grail
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Further Reading
- Five stocks we like better than Grail
- Upcoming IPO Stock Lockup Period, Explained
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.